Kevin Rockich

About Kevin Rockich

Professional Experience1. Sanofi-aventis: Toxicokinetic support for preclinical studies. Clinical pharmacokinetic support for Phase I through Phase studies.2. Procter & Gamble: Project team member for Discovery. PK for lead optimization. PK and TK support for pharmacology and toxicology.3. PostDoc: Neurodegeneration and oxidative stress a focus on dopamine metabolism through monamine oxidase on the formation of free radicals leading to neurodegeneration.4. PhD: Pharmacokinetics and drug metabolism with a focus on animal and human acute phase response effect on drug metaboliams and using PK on changes in drug metabolism enzymes.5. Pharm.D. Goals1. Expert in Pharmacokinetics as it applies to all phases of drug development2. Cotinue to gain experience in Pharmacokinetics Phase II and clinical trials3. Contunue to gain experience in Regulatory support of Phase II and Phase clinical trials as it applies to PharmacokineticsSpecialties: •PK for pre-clinical and clinical data analysis•A project team member for Discovery, early-Development and late phase Development•Writing protocols for toxicokinetic support in toxicology studies, First in Man single and repeat dose studies, drug-drug interaction studies and Phase IIa studies•Proficient in WinNonlin software•Writing the ADME section for IND, IMPD, CIB and NDA regulatory documents•Excellent communication skills and working across functions in a team environment

Experience

1. Senior Director

   Incyte

   Feb 2024 — Present · Wilmington, DE, US

   Clinical Pharmacologist

Education

• Purdue University

  B.S., Pharmacy

  1983 — 1989

• University of Kentucky

  Ph.D./Pharm.D., Pharmacokinetics and Drug Metabolism

  1991 — 1999

Skills

• Drug Development
• Pharmaceutical Industry
• Clinical Trials
• Ind
• Clinical Development
• Pharmacology
• Pharmacokinetics
• Glp
• In Vitro
• Drug Metabolism
• Toxicology